Abstract
Thromboembolism is a major cause of maternal mortality. Recent advances in the management of thromboembolism in pregnancy include the discovery of a new, inherited thrombophilia, an improved understanding of the indications for thromboprophylaxis, and the increased use of low-molecular-weight heparin instead of unfractionated heparin.
MeSH terms
-
Anticoagulants / therapeutic use
-
Female
-
Heparin, Low-Molecular-Weight / therapeutic use
-
Humans
-
Pregnancy
-
Pregnancy Complications, Cardiovascular / drug therapy
-
Pregnancy Complications, Cardiovascular / etiology*
-
Pregnancy Complications, Cardiovascular / mortality
-
Risk Factors
-
Thromboembolism / drug therapy
-
Thromboembolism / etiology*
-
Thromboembolism / mortality
-
Thrombolytic Therapy / methods
Substances
-
Anticoagulants
-
Heparin, Low-Molecular-Weight